Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

162 reductase relationship

12th World AIDS Conference

- Keyword Abstri
ng energy expenditure ( REE ) is associated with increased plasma
tment amongst African Refugee community in UK/Community res
Uganda/Vulnerability of refugee women to HIV/AIDS infection in re
on on HIV prevention for refugees and immigrants/Education on HI
orker, immigrant and /Personal counselling: A strong i
ctice among Sudanese in Adjumani District, northern Ug
e spread of HIV among /Poverty reduction to combat the
Two antiretroviral drugs regime efficacy followed by the use of prog
e/NGC 891: Multidrug in HIV infection as an alternative th
y/Alternative multidrug regimen provides improved suppression o
nts failing a delavirdine /Retrospective analysis of protea
ning triple combination /Clinical trial comparing a ritonavi
bitor treatment in a BID as salvage therapy in advanced
I protease inhibitor (PI) /Efficacy and durability of ritonavi
NA and avipox vaccine /Protective T-cell mediated immu
I of rifabutin added to a of clarithromycin and ethambutol
y/Idarubicin contained in AIDS-related non-Hodgkin's ly
nevirapine as a salvage for indinavir or ritonavir resistanc
valuate a short-course of zidovudine to reduce mother-to
ne-containing anti-HIV /HBs seroconversion of a precore
to a PI containing triple in ART-naive HIV+ patients?/d4
ce-daily clarithromycin /Adherence patterns in patients w
o complex antiretroviral: The perceptions of HIV+ women
dherence to ACTG 076 in a developing country - Porto Al
mbination HIV-1 vaccine /CTL and neutralizing antibody re
ndardized acupuncture for neuropathic pain in HIV patien
ative to 8 hourly dosing: A pilot study/Indinavir 12 hour d
atients on triple therapy regimens /Abacavir (1592, ABC) in protoc
udine (d4T)-containing in the Pacific Oaks Population S
oxyurea in combination for the treatment of antiretroviral
ease inibitor, containing in HIV infected patients/Tolerab
ase inhibitor containing /Associated lipodystrophy meta
oviral effect of two dose of ritonavir and saquinavir used
vase' (SQV) SGC BID in combination with 2 nucleosid
se inhibitors containing:The reasons of absence of initia
o indinavir-containing and associated resistance muta
avioral and therapeutic using a three-component model
iretroviral combination?/Is it safe to stop primary PCP p
mbination antiretroviral for the treatment of HIV infection
dual protease inhibitor may have synergistic antiviral ef
Are nelfinavir containing effective as second line triple th
ue primary prophylaxis in selected HIV-infected patient
otease inhibitors based /Regression of neurocognitive i
viral medication (ARV) in a community-based sample o
rt-course antiretroviral to reduce mother-to-child HIV tr
nhibitor (PI) containing: Is it equal for all?/Access to tre
ultiple monotherapy /Limited treatment options for an
nage complex HIV drug /HIV Therapy Scheduler (HTS):
zed study of nucleoside in antiretroviral (ARV)-naive pati
voxil) added to existing /Genotypic characterization of H
o protease inhibitor (PI) (d4T+3TC+IDV vs. d4T+RTV+S
ase inhibitor-containing according to initial CD4 count/Vi
ntiretroviral therapeutic regimes for the treatment of HIV/AIDS/Inc
e WHO Western Pacific Region (WPRO)/lncreasing antibiotic resi
utations in the HIV gag region that are distal from deletion mutatio
e polymer from the C4 of SIV envelope induces strong cell
ommunities in Mwanza, Tanzania/Geographical variations
e WHO Western Pacific /Reported and estimated HIV and A
United States, by world of birth/Prevalence of tuberculosis
nts living in an endemic?/Coccidioidomycosis: An environ
asis in a Mediterranean: Results of a 10 year survey (1987 -WAs in the Asia Pacific -A PWA perspective/Use of herba
te areas of the amazon in Brazil/AIDS education in remote
DNA viruses regulatory s by HIV-1 Tat: Transactivation mec
ttings in St. Petersburg /Peculiarities of AIDS/STDs preven
munities in the Sydney /Using ethnic media to reach multipl
d children in the Veneto of Italy/Evaluation of the current pr
r families in the Veneto in Italy/Organisation of a network f
workers in the Amazon /NGO's network/working together t
ism in protease coding of seroconverters/Genotypic preva
ubsets in the Free State of South Africa/Normal values for T
eillance system in Lazio, Italy: Update/HIV surveillance syst
S in the Western Pacific /Epidemiological surveillance syste

or the Western Pacific /HIV, AIDS and STD database in us
of Svetlogorsk, Gomel, Belarus/Sentinel surveillance con
widows in the northern of Malawi by Patricia C. Amadi com
g of population, Perm's in Russia/HIV testing of population,
alicia (Spain) and north of Portugal/HIV/AIDS in the fisher
a (Spain) and the north of Portugal/Evaluation of an interve
e from HIV-1 gp120 V3 is reducing PC12 neuronal cell line

act32168
60959
44209
13534
23585
43339
44229
12182
60044
11156
12236
12265
12303
12330
549*/21198
22176
22294
22356
31*/23280
32118
32315
32324
65*/32352
32401
33221
60453
60484
12212
12228
287*/12235
12242
12299
12307
12314
12334
12342
14309
22180
22348
22350
22381
31225
32196
32338
35*/42201
42305
60294
60348
60397
60706
60791
60812
24134
84*/33231
378*/11126
11241
13119
13128
13249
22220
22325
22487
23581
31223
33203
589*/33445
34265
34314
34359
41210
42185
43436
43444

43460
43467
60031
60090
60190
60213
60334

-Keyword

Abstract--

V patients in a Spanish \
9 years in rural Mwanza
sk groups in a suburban /
Eurosida study group/ Regiona

with a high incidence of tuberculosi
Tanzania: A random sample surve
Out-reach prevention program for
II survival differences across Euro

60544
60682
60935
437*/12272

uences in human brain/ quasi-species and amino acid si 21122
nd mortality in Canada/ and gender differentials in patter 24191
bution in HIV infection: body composition measurement 32181
a. Example of the GTZ AIDS Programme for West and 43224
ss through partnership: HIV voluntary service organisati 44267
prevalence/Recency in regional HIV spread progression: 1997 inc 13104
IDA study/Changes in differences within Europe in incid 22127
ve health care costs in a HIV/AIDS population/Comparati 24126
work of sexworkers from to international/Strengthening ne 34349
The success story of a network of AIDS educators in the 34351
e year of progress/The AIDS training network- One year 34354
IV-positive persons is a and local phenomenon/Treatme 42237
IV test: Experience in a population seropositive for HIV 1 43112
ion)/Added value of a approach to improve the respond 43224
ed group, a CBO and a university/HIV/AIDS and men wh 93*/43380
ning capacities through military networking in countries of 359*/43391
opment of national and minority organizations to deliver t 43513
antiretroviral therapy in regions of Europe over time: The EuroSID 22335
are directed to multiple of HIV-1 subtype E/HIV-specific c 599*/31120
DNA viruses regulatory by HIV-1 Tat: Transactivation mec 31223
oung couples in rural of western Kenya/Locally sustain 43114
gh and low risk African for HIV infection/Seroepidemiolo 60723
ata from the National Registry up to December 1997/HIV-2 in S 11207: Data from the National up to December 1997/HTLV-I in 13300
988 and 1992/Using registry data to estimate trends in survival 60253
dian HIV healthline and for women and their families/A na 60669
antiretroviral treatment/ Regression of AIDS-related Kaposi's sarc 22288
bitors based regimens/ of neurocognitive impairment 32196
nd acyclovir therapy/ or stabilization of PML by high 32209
reatment with cidofovir/ of AIDS-related Kaposi's sarc 60324
tments (HAART)/Early regression of cervical lesions in HIV-sero 22312
ps/Flexible parametric for retrospective studies of HIV 60298
AART/Spontaneous regressions of an AIDS-related high-grad 60817
r people living with HIV/ Rehabilitation services for people living wi 22480
ug users in Residential Centres in France, 1993-9 23201
agiselis and Devadasis/ of Mathammas, Joginis, Ba 23423
g to poverty alleviation/ of commercial sex workers 34260
y organizing for HIV and rehabilitation /Positively fit: Community or 24183
orkers/Awareness and of commercial sex workers/ 33279
HIV disease/Vocational in the context of HIV diseas 34112
principles of vocational and return to work in the con 34145
sical and mental health of people living with HIV/AI 34299
community-based HIV services/Pozfit, positively fi 504*/42400
/Counselling, care and of HIV/AIDS positives/Cou 42459
nts with HIV/AIDS on a in-patient service/Experien 60724
erarchy/Reduced STD reinfection and more protected acts with a 33153
e affected by HIV/AIDS/ Reintegration into a family network for pe 34132
rtners among gay men/ Relapse-prevention theory increases und 14142
with interleukin-2 after relapse. Role of the immune reconstitution 22293
ovement after virologic in patients receiving highly active 22342
ated HIV incidence and to unsafe sex among young men h 23118
n: Strategies to prevent /Understanding unsafe sex in you 43274
ated with longer time to in patients with CMV retinitis/Prot 60405
n children/Persistent or relapsing oral candidiasis as an indicator 12196
it in HIV carrier infants/ Relationship between dental eruption del 12167,and didanosine (ddl)/ between delavirdine (DLV) p
y/Oral PMPA pro-drug: between clinical pharmacoki
/Sexual risk behaviour: between sexual orientation
ersons in Venezuela/ between quality of life and so
rimary HIV-1 infection, with HIV-1 RNA, TNF-relate
tinitis in AIDS patients/ between the detection of pla
ection in HIV+ women/ between HIV viral load, CD4
and cervical dysplasia/ of HIV-1 RNA copies in plas
t situation and solution/ between HIV/AIDS acquired
unction in HIV infection: relationship with different prognosis mark
ma drug concentration in Phase III study of nelfinavir
arare, Zimbabwe/The of hepatitis B virus and HIV s
ender differences in the between HIV-1 load and prog
erosexual transmission: with HIV-1 subtypes in Ugan
M-IDU) in Denver/The between sex, drugs, and con
en on methadone/The between HIV risk behavior an
ssues interfering in the between professionals and P
eatment program/The between AZT therapy and de
e first three months of a only may prevent spread of H
vity/Structure/function of trichosanthin (TCS) on anti
I blood: Evaluation and with RNA levels in plasma/HI

12206
12211
14128
14344
21173
22265
22313
22317
60887
12139
12304
13301
13384
23357
23406
23455
24228
32254
33157
41206
42176